Skip to content

Evaluation of postoperative pain by Pain Vision PS-3100, a quantitative analyzer for perception and pain in gastrectomy

Evaluation of postoperative pain by Pain Vision PS-3100, a quantitative analyzer for perception and pain in gastrectomy - Evaluation of postoperative pain by Pain Vision PS-3100, a quantitative analyzer for perception and pain in gastrectomy

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1042250045
Enrollment
60
Registered
2025-06-17
Start date
2025-08-15
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Postoperative pain measurement using Pain Vision and NRS in the open surgery group and the minimally invasive surgery group

Sponsors

Bando Etsuro
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients should be 18 years of age or older at the time of consent, and have a performance status (PS) of 0 or 1 according to the ECOG criteria. (2) Patients scheduled for gastrectomy for gastric cancer.

Exclusion criteria

Exclusion criteria: (1) Patients with peripheral neuropathy (2) Patients on regular analgesic medication (3) Patients who are judged by the principal investigator (or investigators) to be inappropriate for inclusion in this study

Design outcomes

Primary

MeasureTime frame
Difference in pain intensity measured by Pain Vision between the open surgery group and the minimally invasive surgery group on the first postoperative day

Secondary

MeasureTime frame
(1) Correlation between pain intensity by NRS and Pain Vision using correlation coefficient on the 1st, 3rd, 6th, and 8th postoperative days. (2) Comparison of pain intensity by NRS and Pain Vision in terms of patients background factors (gender, age, surgical procedure, ets.)

Contacts

Public ContactYosuke Matsumoto

Shizuoka Cancer Center

yos.matsumoto@scchr.jp+81-55-989-5222

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026